| Literature DB >> 23475316 |
David M Rose1, Toby O Smith, Dominic Nielsen, Caroline B Hing.
Abstract
This study systematically reviews the evidence-base for the use of expandable nails in the treatment of acute diaphyseal fractures of the lower limb. Both electronic and hand searches were undertaken of the published and grey literature to 1 December 2011. A total of 154 citations were identified, of which 15 were deemed suitable and assessed with the Critical Appraisals Skills Programme tool. A total of 625 nailing procedures were performed in 620 patients: 279 femoral and 346 tibial nails. The expandable nail was found to be significantly quicker to insert than interlocked nails (p < 0.05), and the total incidence of non-union or other complication was 13 and 14 % for expandable femoral and tibial nails, respectively. Notable complications with the expandable nail included fracture propagation on nail inflation in 2.5 % and post-operative shortening in 3.3 %. Device failure secondary to problems with the expansion mechanism was seen in 2.9 %. The rate of non-union and infection following expandable nailing was 3.1 and 1.4 %, respectively. Despite promising initial results, there remains a paucity of good quality studies to support the use of expandable nails over interlocked nails for the treatment of acute diaphyseal fractures of the lower limb.Entities:
Year: 2013 PMID: 23475316 PMCID: PMC3623922 DOI: 10.1007/s11751-013-0156-9
Source DB: PubMed Journal: Strategies Trauma Limb Reconstr ISSN: 1828-8928
Search strategy for published databases (AMED, CINAHL, MEDLINE, EMBASE, BNI, HMIC)
| Number | Term |
|---|---|
| 1 | Nail.ti.ab |
| 2 | Expand$ ti.ab |
| 3 | Exp.balloon |
| 4 | Fixon.ti.ab |
| 5 | Exp.fractures,bone |
| 6 | Union.ti.ab |
| 7 | Patholog$ti.ab |
| 8 | Fusion.ti.ab |
| 9 | Exp/Bone |
| 10 | Humer$. ti.ab |
| 11 | Tibia$ti.ab |
| 12 | Femoral. ti.ab |
| 13 | Exp.femur |
| 14 | Subtalar. ti.ab |
| 15 | Exp.ankle |
| 16 | OR/2–4 |
| 17 | AND/1,16 |
| 18 | OR/5–8 |
| 19 | OR/9–15 |
| 20 | AND/17–19 |
| 21 | Remove duplicated/20 |
Search strategy and results for unpublished literature databases
| Database | Term | Result | Result |
|---|---|---|---|
| OpenSIGLE (System for Information on Grey Literature in Europe); WHO International Clinical Trials Registry Platform; UKCRN Portfolio Database; National Technical Information Service; Current Controlled Trials database; National Research Register | 1 | Expandable nail.tw. | 0 |
| 2 | Orthopaedic nail.tw | 0 | |
| 3 | Orthopaedic nail.tw | 0 | |
| 4 | AND/2,3 | 0 | |
| 5 | OR/1,4 | 0 |
CASP results
| Study | Total (20) |
|---|---|
| Lepore et al. [ | 15 |
| Smith et al. [ | 14 |
| Steinberg et al. [ | 14 |
| Ben Galim et al. [ | 13 |
| Bi et al. [ | 12 |
| Fortis et al. [ | 10 |
| Panidis et al. [ | 10 |
| Bekmezci et al. [ | 9 |
| Zocalli et al. [ | 9 |
| Cilli et al. [ | 9 |
| Kapoor et al. [ | 8 |
| Capelli et al. [ | 7 |
| Ozturk et al. [ | 6 |
| Lepore et al. [ | 5 |
| Pascarella et al. [ | 4 |
Criteria
1. Did the review ask a clearly focused question?
2. Was the population clearly defined?
3. Was a cohort study design appropriate (i.e. was one intervention reviewed or 2 or more when a RCT may have been more appropriate)?
4. Did the paper state a clear research question?
5. Was the cohort representative of this population?
6. Was everybody included who should have been included?
7. Were the appropriate outcome measurements used?
8. Did the study identify if the outcome measurements are valid and reliable for this population?
9. Were the measurement methods similar for the different groups?
10. Were the subjects/blinded to the intervention?
11. Was the assessor blinded to the intervention?
12. Did the paper control for confounding variables, for example, population heterogeneity/interventional heterogeneity?
13. Did more than 85 % of the cohort who started the study finish the study?
14. Was the follow-up period sufficiently long enough to determine clinical/radiological outcomes?
15. Has the paper clearly defined the outcomes of the study?
16. Has the paper looked at differences between populations or interventions and assess for this with appropriate statistical test?
17. Were confidence intervals presented to assess the precision of the statistical result?
18. Can the results be attributed to bias/confounding/chance event rather than the effect of the intervention specifically?
19. Are the subjects of the study reflective of this typical population?
20. Do the results of this study fit with other available evidence?
Fig. 1PRISMA chart showing the results of the search strategy
Study demographics
| Study | Study design | Subjects | Mean age, years (range) | Gender (f/m) | Limbs | Follow-up (months) |
|---|---|---|---|---|---|---|
| Lepore et al. [ | Case–control | 86 | 32.5 (18–79) | 22/64 | 86 | N/S |
| Smith et al. [ | Case series | 48 | 25.2 (18–49) | 15/33 | 49 | 16 (9–32) |
| Steinberg et al. [ | Case series | 54 | 40 (19–84) | 17/37 | 54 | 14 (12–24) |
| Ben Galim et al. [ | RCT | 53 | 39.1 (17–84) | 14/39 | 53 | 24 |
| Bi et al. [ | RCT | 46 | 38.4 (20–74) | 19/27 | 46 | 16 (12–34) |
| Fortis et al. [ | Case series | 26 | 38 (17–78) | 5/21 | 26 | 24 |
| Panidis et al. [ | Case series | 20 | 25 (18–62) | N/S | 20 | 15 |
| Bekmezci et al. [ | Case series | 20 | 31 (15–75) | 10/10 | 20 | 26 (9–38) |
| Zocalli et al. [ | Case–control | 93 | 36 (17–62) | N/S | 96 | 15 |
| Cilli et al. [ | Case series | 20 | 34 (18–70) | 5/15 | 20 | 10 (5–16) |
| Kapoor et al. [ | Case series | 32 | 31.8 (18–62) | 8/24 | 32 | 28 (12–43) |
| Capelli et al. [ | Case series | 22 | 48 (8–68) | 10/12 | 22 | 6 |
| Ozturk et al. [ | Case series | 42 | N/S | N/S | 42 | N/S |
| Lepore et al. [ | Case series | 39 | N/S | N/S | 39 | N/S |
| Pascarella et al. [ | Case series | 19 | 37 (14–78) | 6/13 | 20 | N/S |
RCT randomised controlled trial, N/S not specified, f female, m male
Study characteristics
| Study | Limbs | Open/closed fracture | Fracture type (AO-number) | Nail allocation | Reaming | Mean time to union, months (range) | Complications | |
|---|---|---|---|---|---|---|---|---|
| Lepore et al. [ | 86 | Closed | 86 Femora ( | 43 Stratec 43 Fixion | 43 reamed 19 reamed | L—4 (3–9) E—3 (3–9) | L—1 nail breakage | |
| Smith et al. [ | 49 | 37 closed 12 open | 22 Femora ( 27 Tibiae ( | 22 Fixion 27 Fixion | 46/49 reamed | F—4 (2–6) T—3 (2–6) | E—2 tibial delayed unions, 1 femoral and 1 tibial non-union, 5 tibial + 6 femoral Fx shortened, 7 propagation of Fx intra-operatively | |
| Steinberg et al. [ | 54 | 27 closed 27 open | 54 Tibiae ( | 54 Fixion | 30/54 reamed | 3 (1–7) | E—2 superficial infections, 3 deep infections, 2 bone shortening, 1 Fx propagation, 1 distal malalignment | |
| Ben Galim et al. [ | 53 | 26 closed 27 open | 53 Tibiae ( | 26 Mathys 27 Fixion | 7 reamed 5 reamed | L—3 E—4 | L—3 neurological deficits, 3 infections E—no complications | |
| Bi et al. [ | 46 | 34 closed 12 open | 46 Tibiae ( | 24 Locked 22 Fixion | 46 reamed | L—4 ± 1 E—3 ± 1 | L—1 infection, 1 nail breakage | |
| Fortis et al. [ | 26 | 20 closed 6 open | 26 Tibiae ( | 26 Fixion | Unreamed | 3 | E—1 nail failed to expand | |
| Panidis et al. [ | 20 | N/S | 11 Femora ( 9 Tibiae ( | 20 Fixion | Unreamed | N/S | E—3 nails bent at tip, 1 nail failed to expand | |
| Bekmezci et al. [ | 20 | Closed | 20 Femora ( | 20 Fixion | N/S | N/S | No complications | |
| Zocalli et al. [ | 96 | 95 closed 1 open | 45 Femora ( 51 Tibiae ( | 24 locked 21 Fixion 24 locked 27 Fixion | E—4 reamed | N/S | E—1 Fx widening, 1 pneumatic system rupture, 1 nail incarceration, 2 tibial delayed union | |
| Cilli et al. [ | 20 | 19 closed 1 open | 20 Femora ( | 20 Fixion | N/S | 15.2 (12–24) | No complications | |
| Kapoor et al. [ | 32 | Closed | 22 Femora ( 10 Tibiae ( | 22 Fixion 10 Fixion | 22 reamed 10 reamed | F—5 (4–11) T—5 (3–9) | F—2 delayed union, 1 femoral nail bent after repeated trauma T—1 delayed union with infection | |
| Capelli et al. [ | 22 | Closed | 22 Tibiae ( | 22 Fixion | Unreamed | T—4 (3–5) | T—1 superficial infection | |
| Ozturk et al. [ | 42 | N/S | 29 Femora ( 13 Tibiae ( | 29 Fixion 13 Fixion | N/S | N/S | E—2 rotationally unstable nails progressed to non-union, 1 nail deflation with pseudoarthrosis, 1 longitudinal fracture propagation, 1 nail bent during weight bearing with further fracture development, 1 inserter connector breakage and nail could not be inflated or removed | |
| Lepore et al. [ | 39 | N/S | 9 Femora ( 13 Tibiae ( (17 unavailable for follow-up) | 9 Fixion 13 Fixion | 16 reamed | F—2 (N/S) T—3 (N/S) | E—2 fracture propagation on nail insertion | |
| Pascarella et al. [ | 20 | N/S | 8 Femora ( 12 Tibiae ( | 8 Fixion 12 Fixion | 20 reamed | F—5 (4–7) T—4 (3–6) | E—1 refracture with bending of nail, 1 nail thread bit of inflator broke off and remained in nail, 1 nail sprang a leak | |
OI osteogenesis imperfecta, N/S not specified, L locked nail, E expandable nail, Fx fracture, F femur, T tibia
Bold values indicate AO long bone fracture classification
Fig. 2a–d Radiographs demonstrating treatment of an acute tibial shaft fracture with the Fixion™ expandable nail
Complications of femoral and tibial expandable nails
| Complication | Overall complication rate (%) | Femoral | Tibial | References |
|---|---|---|---|---|
| Non-union or delayed union | 3.1 | 2.4 % | 3.7 % | [ |
| Shortening | 3.3 | 3.8 % | 2.9 % | [ |
| Fracture propagation | 2.5 | N/A | N/A | [ |
| Implant failure | 2.9 | 4.2 % | 1.8 % | [ |
| Infection | 1.4 | 0 % | 2.6 % | [ |
N/A data not available